These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 4327046)

  • 21. [Hormone therapy of menopause and osteoporosis].
    Fugère P
    Union Med Can; 1987 Mar; 116(3):163-6. PubMed ID: 3590379
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
    Chandeying V; Sangthawan M
    J Med Assoc Thai; 2007 Sep; 90(9):1720-6. PubMed ID: 17957910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prescription of compensatory estrogens-progestagens in the menopause].
    Colau JC
    Soins Gynecol Obstet Pueric Pediatr; 1989; (97-98):13-4. PubMed ID: 2762993
    [No Abstract]   [Full Text] [Related]  

  • 24. [Principles of replacement hormone therapy in climacteric disorders].
    Smetnik VP
    Akush Ginekol (Mosk); 1995; (3):15-7. PubMed ID: 7653720
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical trial of a new synthetic estroprogestinic agent in the climacteric and menopause].
    Moggian G; Tamburini E
    Riv Ital Ginecol; 1970; 54(4):265-76. PubMed ID: 4949808
    [No Abstract]   [Full Text] [Related]  

  • 26. [Newer aspects of hormonal therapy in gynecology].
    Kaiser E; Loch EG
    Z Allgemeinmed; 1975 May; 51(13):600-5. PubMed ID: 1216894
    [No Abstract]   [Full Text] [Related]  

  • 27. [Estrogen therapy in the climacteric].
    Kaiser R
    Dtsch Med Wochenschr; 1978 Jun; 103(26):1059-61. PubMed ID: 668516
    [No Abstract]   [Full Text] [Related]  

  • 28. Indications for therapy with progestational agents.
    Darragh A
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):541-4. PubMed ID: 5534331
    [No Abstract]   [Full Text] [Related]  

  • 29. Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
    Lobo RA; McCormick W; Singer F; Roy S
    Obstet Gynecol; 1984 Jan; 63(1):1-5. PubMed ID: 6318170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of 'natural' oestrogen replacement therapy on menopausal symptoms.
    Coope J
    Postgrad Med J; 1976; 52 Suppl 6():27. PubMed ID: 185604
    [No Abstract]   [Full Text] [Related]  

  • 31. [Psychometric aspects of estrogen therapy in climacteric woman (study of 122 women after menopause].
    Wenderlein JM
    Z Klin Psychol Psychother; 1981; 29(3):263-7. PubMed ID: 6274104
    [No Abstract]   [Full Text] [Related]  

  • 32. Vasomotor symptoms and estrogen-progestogen therapy.
    von Schoultz B
    Acta Obstet Gynecol Scand Suppl; 1985; 132():15-8. PubMed ID: 3161264
    [No Abstract]   [Full Text] [Related]  

  • 33. Sequential use of conjugated estrogens and medroxyprogesterone in the climacteric syndrome: clinical and histological findings.
    Figueroa-Casas PR; Schlaen I
    Maturitas; 1988 Mar; 9(4):309-13. PubMed ID: 2837619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of a "conventional" estro-progestinic drug at low dosage in premenopausal and menopausal women].
    Berghella A
    Minerva Ginecol; 1976 May; 28(5):456-7. PubMed ID: 1018827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of hirsutism using cyproterone acetate].
    Hammerstein J; Cupceancu B
    Dtsch Med Wochenschr; 1969 Apr; 94(16):829-34. PubMed ID: 4304873
    [No Abstract]   [Full Text] [Related]  

  • 36. I have recently started taking Prempro (0.625 mg conjugated estrogens/2.5 mg medroxyprogesterone acetate). There is so much written about the benefits of taking estrogen, but I am wondering about the effects of the progesterone component. Will it counteract the benefits of estrogen?
    Robb-Nicholson C
    Harv Womens Health Watch; 1999 Jan; 6(5):8. PubMed ID: 9916577
    [No Abstract]   [Full Text] [Related]  

  • 37. [Substitution therapy with equiline sulfate in menopausal women].
    Ravid R; Ayalon D
    Harefuah; 1973 Sep; 85(5):218-9. PubMed ID: 4356880
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hormonal treatment of climacteric syndrome].
    Dapunt O
    Ther Ggw; 1971 Jan; 110(1):34-50. PubMed ID: 5545646
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical study of a synthetic estro-progestational agent: FH 080].
    Villedieu P
    Presse Med (1893); 1966 Nov; 74(51):2625-6. PubMed ID: 5926994
    [No Abstract]   [Full Text] [Related]  

  • 40. [Possibilities of hormonal therapy in climacteric disorders with special reference to a new method of oral oestrogen treatment (author's transl)].
    Andor J
    Ther Umsch; 1974 Mar; 31(3):182-7. PubMed ID: 4816757
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.